SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16 | -99.2% | 2 | -99.3% | 0.00% | – |
| Q3 2022 | $2,000 | – | 277 | +465.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 49 | -99.8% | 0.00% | – |
| Q1 2022 | $223,000 | -47.0% | 27,173 | -4.0% | 0.00% | – |
| Q4 2021 | $421,000 | +6.3% | 28,312 | +35.2% | 0.00% | – |
| Q3 2021 | $396,000 | +10.6% | 20,935 | +8.5% | 0.00% | – |
| Q2 2021 | $358,000 | -42.7% | 19,287 | -33.0% | 0.00% | – |
| Q4 2020 | $625,000 | – | 28,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |